Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04692779 · ClinicalTrials.gov registry record
A Prospective Clinical Study to Explore Response to Prone Positioning in ARDS Patients
A clinical trial, sponsored by Rush University Medical Center.
- Completed
- Registry status
- 60
- Enrollment target
NCT04692779: Completed study, sponsored by Rush University Medical Center.
NCT04692779 is a clinical trial that has completed, run by Rush University Medical Center. The registered enrollment target is 60 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04692779 has completed, sponsored by Rush University Medical Center.
- COMPLETED
- Registry status
- 60 participants
- Enrollment target
Study Summary
The proposed study will be conducted to investigate the mechanism of patients' responses to prone positioning with coronavirus disease 2019 (COVID-19) acute respiratory distress syndrome (ARDS) and non-COVID-19 ARDS utilizing lung ultrasound.
Primary Outcome
Patients' responses of oxygenation and lung ultrasound score (0 - 36 where 0 = normal lung aeration and 36 = most severe lung consolidation) to prone positioning in the first three prone positioning sessions for ARDS patients.
Interventions
- OTHER Lung Ultrasound (LUS)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 60 participants |
| Start Date | 2021-01-31 |
| Est. Completion | 2024-12-06 |
What the finished NCT04692779 record still lists
NCT04692779 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 60 participants, a relatively small participant target.
The record links to 0 conditions, and to 1 intervention - of which Lung Ultrasound (LUS) is the first listed.
NCT04692779 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04692779 about?
NCT04692779 is a clinical study titled "A Prospective Clinical Study to Explore Response to Prone Positioning in ARDS Patients". The proposed study will be conducted to investigate the mechanism of patients' responses to prone positioning with coronavirus disease 2019 (COVID-19) acute respiratory distress syndrome (ARDS) and non-COVID-19 ARDS utilizing lung ultrasound.
What is the current status of trial NCT04692779?
This trial is currently completed. The enrollment target is 60 participants. The study started on 2021-01-31. Estimated completion is 2024-12-06.
What interventions are being tested in trial NCT04692779?
The interventions under investigation include: Lung Ultrasound (LUS) (OTHER).
Who is sponsoring clinical trial NCT04692779?
This trial is sponsored by Rush University Medical Center, which has 320 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00576069 · 60 participants
Mechanism(s)of Airflow Limitation in Moderate-severe Persistent Asthma
- NCT01297400 · 60 participants · Phase 2
Phase 2 Pilot Study of the Safety and Efficacy of Topical MW-III in Thermal Burns
- NCT01734122 · 60 participants
Stereotactic Radiosurgery for Essential Tremor and Parkinsonian Tremor
- NCT01804634 · 60 participants · Phase 2
Reduced Intensity Haploidentical BMT for High Risk Solid Tumors
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI